P M Kemp1, G A Maguire, N J Bird. 1. Department of Nuclear Medicine, Addenbrooke's NHS Trust, Cambridge, UK.
Abstract
OBJECTIVE: To determine whether the level of prostate-specific antigen (PSA) can be used to decide which patients with newly diagnosed prostatic carcinoma require a staging bone scan. PATIENTS AND METHODS: Of patients referred during an 18-month period for a staging bone scan, 98 (median age 72 years, range 52-89) had had their serum PSA level determined within 4 weeks of the bone scan and were assessed retrospectively for the presence of bony metastases. RESULTS: Of the 98 patients, 26 who had bone scans showing bony metastases had a PSA level > 40 ng/mL. Reviewing the other published studies showed that in those newly diagnosed patients with a PSA level of < 20 ng/mL, the probability of having bony metastases detected on a bone scan was < 1%. CONCLUSIONS: A staging bone scan can be omitted in the vast majority of patients with newly diagnosed prostatic carcinoma and a PSA level < 20 ng/mL.
OBJECTIVE: To determine whether the level of prostate-specific antigen (PSA) can be used to decide which patients with newly diagnosed prostatic carcinoma require a staging bone scan. PATIENTS AND METHODS: Of patients referred during an 18-month period for a staging bone scan, 98 (median age 72 years, range 52-89) had had their serum PSA level determined within 4 weeks of the bone scan and were assessed retrospectively for the presence of bony metastases. RESULTS: Of the 98 patients, 26 who had bone scans showing bony metastases had a PSA level > 40 ng/mL. Reviewing the other published studies showed that in those newly diagnosed patients with a PSA level of < 20 ng/mL, the probability of having bony metastases detected on a bone scan was < 1%. CONCLUSIONS: A staging bone scan can be omitted in the vast majority of patients with newly diagnosed prostatic carcinoma and a PSA level < 20 ng/mL.
Authors: Ashraf J Abusamra; Shouki Bazarbashi; Yasser Bahader; Hussain Kushi; Danny Rabah; Dany Rabbah; Naser Al Bogami; Khalid Al Ghamdi; Abdullah Al Ghamdi; Khaled Balaraj; Raouf Seyam; Mohammed Al Otaibi; Eyad Al Saeed Journal: Urol Ann Date: 2011-03
Authors: Ismet Sarikaya; Ali Sarikaya; Abdelhamid H Elgazzar; Vuslat Yurut Caloglu; Prem Sharma; Ali Baqer; Murat Caloglu; Mahmoud Alfeeli Journal: World J Nucl Med Date: 2018 Oct-Dec
Authors: Ashraf Abusamra; Esam Murshid; Hussain Kushi; Sultan Alkhateeb; Mubarak Al-Mansour; Ahmad Saadeddin; Danny Rabah; Shouki Bazarbashi; Mohammed Alotaibi; Abdullah Alghamdi; Khalid Alghamdi; Abdullah Alsharm; Imran Ahmad Journal: Urol Ann Date: 2016 Apr-Jun
Authors: Ali Aljubran; Ashraf Abusamra; Sultan Alkhateeb; Mohammed Alotaibi; Danny Rabah; Shouki Bazarbashi; Hussain Alkushi; Mubarak Al-Mansour; Hulayel Alharbi; Amin Eltijani; Abdullah Alghamdi; Abdullah Alsharm; Imran Ahmad; Esam Murshid Journal: Urol Ann Date: 2018 Apr-Jun